Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

Browse

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Corrigendum to Tocilizumab as salvage treatment of refractory pulmonary acute graft-versus-host disease

Journal of Oncology Pharmacy Practice

Impact Factor: 1.3 / 5-Year Impact Factor: 1.3

Journal Homepage Submission guidelines

Restricted access

Correction

First published online December, 2020

Corrigendum to Tocilizumab as salvage treatment of refractory pulmonary acute graft-versus-host disease

Volume 26, Issue 8

https://doi.org/10.1177/1078155220960934

Abstract

Get full access to this article

View all access options for this article.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Restricted access

Clinical utility of immature granulocyte monitoring for optimizing g-CSF use during chemotherapy-induced neutropenia

Restricted access

Cost analysis of closed-system transfer devices in bortezomib handling in a Brazilian cancer center

Restricted access

Possible anaphylaxis to palonoestron

Restricted access

Mirvetuximab soravtansine dosing weight considerations